A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME)
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0300930 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, 2024. Verfasst von Claire Fayad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Arts and Sciences, Holy Spirit University of Kaslik-Jounieh, Lebanon. Hauptthemen laut MEDLINE: Myoclonic Epilepsy, Juvenile, Epilepsy, Absence, Drug Resistant Epilepsy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Holy Spirit University of Kaslik - Faculty of Arts and Sciences.
Abstract (Originalsprache)
Introduction
Juvenile Myoclonic Epilepsy (JME) is a prevalent form of epileptic disorder, specifically categorized within the realm of Genetic Generalized Epilepsy (GGE). Its hallmark features encompass unprovoked bilateral myoclonus and tonic-clonic seizures that manifest during adolescence. While most JME patients respond favorably to anti-seizure medication (ASM), a subset experiences refractory JME, a condition where seizures persist despite rigorous ASM treatment, often termed “Drug-Resistant Epilepsy” (DRE). This systematic review and meta-analysis aims to determine the prevalence of refractory JME, and further to identify socio-demographic, electrophysiological and clinical risk factors associated with its occurrence. Pinpointing these factors is crucial as it offers the potential to predict ASM responsiveness, enabling early interventions and tailored care strategies for patients. Material and methods The systematic review and meta-analysis followed the Cochrane Handbook and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The study evaluated outcomes post ASM treatment in JME cohorts by searching papers published up to September 2023 in PubMed/MEDLINE, Scopus, and Google Scholar databases. Predefined inclusion criteria were met by 25 eligible studies, forming the basis for analysis.
Results
A total of 22 potential risk factors for refractory JME were documented. Notably, robust risk factors for treatment resistance included Psychiatric Disorder (Odds Ratio (OR), 3.42 [2.54, 4.61] (95% Confidence Inverval (Cl)), Febrile Seizures (OR, 1.83 [1.14, 2.96] (95% Cl)), Alcohol Consumption (OR, 16.86 [1.94, 146.88] (95%Cl)), Aura (OR, 2.15 [1.04, 4.47] (95%Cl)), childhood absence epilepsy (CAE) evolving into JME (OR, 4.54 [1.61, 12.78] (95%CI)), occurrence of three seizure types (OR, 2.96 [1.96, 4.46] (95%CI)), and Focal EEG abnormalities (OR, 1.85 [1.13, 3.01] (95%Cl)). In addition, there were some non-significant risk factors for DRE because of noticeable heterogeneity.
Conclusion
In aggregate, over 36% of JME patients demonstrated drug resistance, with seven significant risk factors closely linked to this refractoriness. The interplay between these factors and whether they denote treatment non-response or heightened disease burden remains an open question and more studies would be required to fully examine their influence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Arts and Sciences, Holy Spirit University of Kaslik-Jounieh, Lebanon.
- School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
- Applied Science Research Center, Applied Science Private University, Amman, Jordan.
- School of Biosciences, University of Kent, Canterbury, United Kingdom.
ORCID-Profile: Kely Saad, Souheil Hallit, Darren Griffin, Elissar El-Hayek
Förderung
- Holy Spirit University of Kaslik - Faculty of Arts and Sciences
Zitieren
APA
Fayad, C., Saad, K., Kahwagi, G. J., Hallit, S., Griffin, D., Abou-Khalil, R., & El-Hayek, E. (2024). A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME). PLOS ONE. https://doi.org/10.1371/journal.pone.0300930
Vancouver
Fayad C, Saad K, Kahwagi GJ, Hallit S, Griffin D, Abou-Khalil R, et al. A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME). PLOS ONE. 2024. doi:10.1371/journal.pone.0300930
BibTeX
@article{Fayad2024,
author = {Fayad, Claire and Saad, Kely and Kahwagi, Georges-Junior and Hallit, Souheil and Griffin, Darren and Abou-Khalil, Rony and El-Hayek, Elissar},
title = {A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME)},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0300930}
}
EUVIMED